RESEARCH-USE BIOSIMILAR ANTIBODY

Perakizumab

Monoclonal antibody · IgG1

IL17AIgG1RUO

Perakizumab (RG4934) is a humanized IgG1κ monoclonal antibody against IL-17A (Interleukin Related). Perakizumab can be uesd for the research of autoimmune diseases, such as psoriatic arthritis.

TARGETIL17A
YMonoclonal antibody
CATALOGSC-BS-280
CATALOG NUMBERSC-BS-280
MOLECULAR WEIGHTApprox. 145.8 kDa
PRODUCT FORMATMonoclonal antibody

A research-use configuration for comparative antibody studies

Perakizumab (RG4934) is a humanized IgG1κ monoclonal antibody against IL-17A (Interleukin Related). Perakizumab can be uesd for the research of autoimmune diseases, such as psoriatic arthritis.

Perakizumab is a recombinant research-use antibody directed against IL17A.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte
Perakizumab | StellaCyte